|
WO2021081172A1
|
|
Sulfur-containing inorganic-organic hybrid materials and methods for making the same
|
|
US2021113323A1
|
|
Mucosal exclusion anastomosis device and methods
|
|
WO2021076981A1
|
|
Methods and systems for modulating cellular activation
|
|
WO2021077132A1
|
|
Methods and compositions comprising modified fab scaffolds and protein g fab binding domains
|
|
WO2021072435A2
|
|
Methods and systems for detection of nucleic acid modifications
|
|
WO2021071824A1
|
|
Large lateral scale two-dimensional materials and other thin films, and associated systems and methods
|
|
WO2021067952A1
|
|
Targeted nanomedicine for treating vascular disorders
|
|
WO2021067259A1
|
|
Lamellar iron sulfides with embedded cations for electrical energy storage
|
|
WO2021062238A1
|
|
Methods and compositions for treating sickle cell disease and thalassemia
|
|
WO2021061702A1
|
|
Method of creating zero-burden digital biomarkers for disorders, and exploiting co-morbidity patterns to drive early intervention
|
|
WO2021055960A1
|
|
Photoproximity profiling of protein-protein interactions in cells
|
|
US2021085653A1
|
|
Compositions and methods for treating and preventing post- cardiopulmonary resuscitation injury
|
|
WO2021051136A1
|
|
Methods and compositions for treating staphylococcal infections
|
|
WO2021050923A1
|
|
Method and apparatus using machine learning for evolutionary data-driven design of proteins and other sequence defined biomolecules
|
|
WO2021051130A1
|
|
Combination therapy for the treatment of migraines
|
|
WO2021050541A1
|
|
System and method of partial compilation with variational algorithms for quantum computers
|
|
US2021053042A1
|
|
Strongly lewis acidic metal-organic frameworks for continuous flow catalysis
|
|
US2021056867A1
|
|
Millifluidic system for thrombosis analysis under patient-specific physiological conditions
|
|
WO2021030724A1
|
|
Heterogeneous rare-earth doped systems
|
|
WO2021016640A1
|
|
Compositions and methods comprising protease-activated therapeutic agents
|
